Impact of IL28B, ITPA and PNPLA3 Genetic Variants on Therapeutic Outcome and Progression of Hepatitis C Virus Infection

References

• Choo QL , KuoG , WeinerAJ , OverbyLR , BradleyDW , HoughtonM . Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome . Science244 ( 4902 ), 359 – 362 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Robertson B , MyersG , HowardCet al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy . Arch. Virol.143 ( 12 ), 2493 – 2503 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Simmonds P , BukhJ , CombetCet al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes . Hepatology42 ( 4 ), 962 – 973 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Simmonds P , HolmesEC , ChaTAet al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region . J. Gen. Virol.74 ( Pt 11 ), 2391 – 2399 ( 1993 ).
   PubMedGoogle Scholar
• Smith DB , BukhJ , KuikenCet al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource . Hepatology59 ( 1 ), 318 – 327 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kiyosawa K , SodeyamaT , TanakaEet al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus . Hepatology12 ( 4 Pt 1 ), 671 – 675 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Tong MJ , El-FarraNS , ReikesAR , CoRL . Clinical outcomes after transfusion-associated hepatitis C . N. Engl. J. Med.332 ( 22 ), 1463 – 1466 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Roudot-Thoraval F , BastieA , PawlotskyJM , DhumeauxD . Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus . Hepatology26 ( 2 ), 485 – 490 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Ge D , FellayJ , ThompsonAJet al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance . Nature461 ( 7262 ), 399 – 401 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thomas DL , ThioCL , MartinMPet al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus . Nature461 ( 7265 ), 798 – 801 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tillmann HL , ThompsonAJ , PatelKet al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice . Gastroenterology139 ( 5 ), 1586 – 1592 , 1592 e1581 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bochud PY , BibertS , NegroFet al. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C . J. Hepatol.55 ( 5 ), 980 – 988 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Stenkvist J , SonnerborgA , WeilandO . HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism . J. Viral Hepat.20 ( 3 ), 193 – 199 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sarrazin C , SusserS , DoehringAet al. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients . J. Hepatol.54 ( 3 ), 415 – 421 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mccarthy JJ , LiJH , ThompsonAet al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin . Gastroenterology138 ( 7 ), 2307 – 2314 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Moghaddam A , MelumE , ReintonNet al. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection . Hepatology53 ( 3 ), 746 – 754 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rauch A , KutalikZ , DescombesPet al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study . Gastroenterology138 ( 4 ), 1338 – 1345 , 1345 e1331–1337 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Suppiah V , MoldovanM , AhlenstielGet al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy . Nat. Genet.41 ( 10 ), 1100 – 1104 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tanaka Y , NishidaN , SugiyamaMet al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C . Nat. Genet.41 ( 10 ), 1105 – 1109 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Poordad F , BronowickiJP , GordonSCet al. Factors that predict response of patients with hepatitis C virus infection to boceprevir . Gastroenterology143 ( 3 ), 608 – 618 , e601–605 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jacobson I , CatlettI , MarcellinPet al. 1369 Telaprevir substantially improved SVR rates across all IL28B genotypes in the advance trial . J. Hepatol.54 , S542 – S543 ( 2011 ).
   Web of Science ®Google Scholar
• Poordad F , LawitzE , KowdleyKet al. 1399 12-Week interferon-free regimen of abt-450/r+ abt-333+ ribavirin achieved svr12 in more than 90% of treatment-naive hcv genotype-1-infected subjects and 47% of previous non-responders . J. Hepatol.56 , S549 – S550 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zeuzem S , SorianoV , AsselahTet al. Faldaprevir and deleobuvir for HCV genotype 1 infection . N. Engl. J. Med.369 ( 7 ), 630 – 639 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kwo PNG , NahassR , BernsteinDet al. A Phase 3, Randomised, open-label study to evaluate the efficacy and safety of 8 and 12 weeks of simeprevir plus sofosbuvir in treatment-naive and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: Optimist-1 . J. Hepatol.62 ( Suppl. 2 ), S270 ( 2015 ).
   Google Scholar
• Kumada H , SuzukiY , IkedaKet al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection . Hepatology59 ( 6 ), 2083 – 2091 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bochud PY , BibertS , KutalikZet al. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes . Hepatology55 ( 2 ), 384 – 394 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Abe H , OchiH , MaekawaTet al. Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients . J. Hepatol.53 ( 3 ), 439 – 443 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Noureddin M , WrightEC , AlterHJet al. Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis . Hepatology58 ( 5 ), 1548 – 1557 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rembeck K , AlsioA , ChristensenPBet al. Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3 . PLoS ONE7 ( 1 ), e29370 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rembeck K , WestinJ , LindhM , HellstrandK , NorkransG , LagingM . Association between interleukin-28B-related genetic variants and liver histopathology differs between hepatitis C virus genotypes . Hepatology56 ( 1 ), 394 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ydreborg M , WestinJ , RembeckKet al. Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection . PLoS ONE8 ( 11 ), e80172 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mirandola S , RealdonS , IqbalJet al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis . Gastroenterology130 ( 6 ), 1661 – 1669 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Jackel-Cram C , BabiukLA , LiuQ . Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core . J. Hepatol.46 ( 6 ), 999 – 1008 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Abid K , PazienzaV , De GottardiAet al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation . J. Hepatol.42 ( 5 ), 744 – 751 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Jackel-Cram C , BabiukLA , LiuQ . Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core . J. Hepatol.46 ( 6 ), 999 – 1008 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Abid K , PazienzaV , De GottardiAet al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation . J. Hepatol.42 ( 5 ), 744 – 751 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Westin J , NordlinderH , LaggingM , NorkransG , WejstalR . Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients . J. Hepatol.37 ( 6 ), 837 – 842 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Metz P , ReuterA , BenderS , BartenschlagerR . Interferon-stimulated genes and their role in controlling hepatitis C virus . J. Hepatol.59 ( 6 ), 1331 – 1341 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Alberts B JA , LewisJ , RaffM , RobertsK , WalterP . Molecular Biology Of The Cell, Fouth Edition . Garland Science , NY, USA , 884 – 886 ( 2002 ).
   Google Scholar
• Dill MT , DuongFH , VogtJEet al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C . Gastroenterology140 ( 3 ), 1021 – 1031 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Honda M , SakaiA , YamashitaTet al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C . Gastroenterology139 ( 2 ), 499 – 509 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Prokunina-Olsson L , MuchmoreB , TangWet al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus . Nat. Genet.45 ( 2 ), 164 – 171 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Terczynska-Dyla E , BibertS , DuongFHet al. Reduced IFNlambda4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes . Nat. Commun.5 , 5699 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hamming OJ , Terczynska-DylaE , VieyresGet al. Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses . EMBO J.32 ( 23 ), 3055 – 3065 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jouvin-Marche E , Macek JilkovaZ , TheluMAet al. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels . J. Infect. Dis.209 ( 12 ), 1907 – 1915 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maeda T , SumiS , UetaAet al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population . Mol. Genet. Metab.85 ( 4 ), 271 – 279 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Shipkova M , LorenzK , OellerichM , WielandE , Von AhsenN . Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population . Clin. Chem.52 ( 2 ), 240 – 247 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Lin S , MclennanAG , YingKet al. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene . J. Biol. Chem.276 ( 22 ), 18695 – 18701 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Chanda PK , RoyJ , BanerjeeAK . In vitro synthesis of genome length complementary RNA of vesicular stomatitis virus in the presence of inosine 5′-triphosphate . Virology129 ( 1 ), 225 – 229 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Simone PD , PavlovYI , BorgstahlGE . ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics . Mutat. Res.753 ( 2 ), 131 – 146 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mohandas T , SparkesRS , PassageMB , SparkesMC , MilesJH , KabackMM . Regional mapping of ADA and ITP on human chromosome 20: cytogenetic and somatic cell studies in an X/20 translocation . Cytogenet. Cell Genet.26 ( 1 ), 28 – 35 ( 1980 ).
   PubMedGoogle Scholar
• Sumi S , MarinakiAM , ArenasMet al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency . Hum. Genet.111 ( 4–5 ), 360 – 367 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Vanderheiden BS . Genetic studies of human erythrocyte inosine triphosphatase . Biochem. Genet.3 ( 3 ), 289 – 297 ( 1969 ).
   PubMed Web of Science ®Google Scholar
• Stocco G , CheokMH , CrewsKRet al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia . Clin. Pharmacol. Ther.85 ( 2 ), 164 – 172 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Waisertreiger IS , MenezesMR , RandazzoJ , PavlovYI . Elevated levels of DNA strand breaks induced by a base analog in the human cell line with the P32T ITPA variant . J. Nucleic Acids.2010 , pii:872180 ( 2010 ).
   PubMedGoogle Scholar
• Fellay J , ThompsonAJ , GeDet al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C . Nature464 ( 7287 ), 405 – 408 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Eskesen AN , MelumE , MoghaddamAet al. Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort . Eur. J. Gastroenterol. Hepatol.24 ( 8 ), 890 – 896 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Clark PJ , AghemoA , DegasperiEet al. Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy . J. Viral Hepat.20 ( 12 ), 858 – 866 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Thompson AJ , SantoroR , PiazzollaVet al. Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR . Hepatology53 ( 2 ), 389 – 395 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ogawa E , FurusyoN , KajiwaraEet al. Comparative safety study on severe anemia by simeprevir- versus telaprevir-based triple therapy for chronic hepatitis C . J. Gastroenterol. Hepatol. doi:10.1111/jgh.12945 ( 2015 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Asselah T , ZeuzemS , SorianoVet al. 1186 itpa gene variants predict hemolytic ribavirin induced anaemia in patients treated with the interferon-free regimen of faldaprevir, BI 207127 and ribavirin in sound-C2 . J. Hepatol.58 , S482 ( 2013 ).
   Web of Science ®Google Scholar
• Thompson AJ , ClarkPJ , SinghAet al. Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients . J. Hepatol.56 ( 2 ), 313 – 319 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• De Franceschi L , FattovichG , TurriniFet al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage . Hepatology31 ( 4 ), 997 – 1004 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Hitomi Y , CirulliET , FellayJet al. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function . Gastroenterology140 ( 4 ), 1314 – 1321 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rembeck K , WaldenstromJ , HellstrandKet al. Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3 . Hepatology59 ( 6 ), 2131 – 2139 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Holmes JA , RobertsSK , AliRJet al. ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response . Hepatology59 ( 6 ), 2152 – 2160 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kurosaki M , TanakaY , TanakaKet al. Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin . Antivir. Ther.16 ( 5 ), 685 – 694 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• He S , McphaulC , LiJZet al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis . J. Biol. Chem.285 ( 9 ), 6706 – 6715 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Romeo S , KozlitinaJ , XingCet al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease . Nat. Genet.40 ( 12 ), 1461 – 1465 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Huang Y , HeS , LiJZet al. A feed-forward loop amplifies nutritional regulation of PNPLA3 . Proc. Natl Acad. Sci. USA107 ( 17 ), 7892 – 7897 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Valenti L , Al-SerriA , DalyAKet al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease . Hepatology51 ( 4 ), 1209 – 1217 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Speliotes EK , ButlerJL , PalmerCDet al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease . Hepatology52 ( 3 ), 904 – 912 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Stickel F , BuchS , LauKet al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians . Hepatology53 ( 1 ), 86 – 95 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Corradini SG , BurzaMA , MolinaroA , RomeoS . Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma . Hepatology53 ( 5 ), 1776 ; author reply 1777 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Valenti L , RumiM , GalmozziEet al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C . Hepatology53 ( 3 ), 791 – 799 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Trepo E , PradatP , PotthoffAet al. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C . Hepatology54 ( 1 ), 60 – 69 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cai T , DufourJF , MuellhauptBet al. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis . J. Hepatol.55 ( 3 ), 529 – 535 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Valenti L , AghemoA , StattermayerAFet al. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin . Aliment Pharmacol. Ther.35 ( 12 ), 1434 – 1442 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pirazzi C , AdielsM , BurzaMAet al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro . J. Hepatol.57 ( 6 ), 1276 – 1282 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kumari M , SchoiswohlG , ChitrajuCet al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase . Cell Metab.15 ( 5 ), 691 – 702 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Burza MA , MolinaroA , AttiliaMLet al. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis . Liver Int.34 ( 4 ), 514 – 520 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kollerits B , CoassinS , BeckmannNDet al. Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins . Hum. Mol. Genet.18 ( 23 ), 4669 – 4676 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Rembeck K , MaglioC , LaggingMet al. PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection . BMC Med. Genet.13 , 82 ( 2012 ).
   PubMed Web of Science ®Google Scholar